Please assess the completion status of the following clinical trial:

Trial Title: Resveratrol's Effects in Diabetic Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes mellitus (DM)~* Controlled blood sugar \[fasting blood sugar (FBS) \<130mg/dl and glycosylated hemoglobin (A1C)\<7%~* Urine albumin \>20mg/lit in two separate occasions during the last 3 months period~* Serum creatinin \< or = 2mg/dl~Exclusion Criteria:~* Pregnancy~* Lactation~* Alcoholism~* Liver failure (acute or chronic)~* Renal failure: serum creatinin \>2mg/dl~* Glomerulonephritis~* Uncontrolled hypertension~* Congestive heart failure~* Prostate disease~* Malignancy~* Bilateral renal artery stenosis~* Any systemic disease other than DM~* Any infection or rheumatologic disorder~* Use of warfarin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Resveratrol (Type: EXPERIMENTAL): Resveratrol + Losartan
- Placebo (Type: PLACEBO_COMPARATOR): Placebo + Losartan

Based on this trial design, predict the completion outcome and termination type (if applicable).